Literature DB >> 22178577

Platelets and primary haemostasis.

Kenneth J Clemetson1.   

Abstract

Platelets have a critical role in haemostasis when vessel wall is injured. Platelet receptors are involved in sequence in this process by slowing platelets down via GPIb/von Willebrand factor to bring them into contact with exposed collagen, then activating them via GPVI to release granule contents and express integrins in a matrix protein binding state. More platelets are incorporated into the growing thrombus and a series of events are set off that finishes with the exposed subendothelium protected by a non-thrombogenic platelet surface and tissue repair underway and the blood flow through the vessel maintained. GPIb is also involved in thrombin activation and, together with GPVI, in the formation of COAT platelets. In thrombosis, pathological changes occur that may lead to life-threatening blockage of vessels. Prevention of thrombosis while maintaining haemostasis remains a major goal of medical research.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22178577     DOI: 10.1016/j.thromres.2011.11.036

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  56 in total

1.  Thromboelastography: A Practice Summary for Nurse Practitioners Treating Hemorrhage.

Authors:  Eliezer Bose; Marilyn Hravnak
Journal:  J Nurse Pract       Date:  2015 Jul-Aug       Impact factor: 0.767

2.  Assessment of roles for the Rho-specific guanine nucleotide dissociation inhibitor Ly-GDI in platelet function: a spatial systems approach.

Authors:  Anh T P Ngo; Marisa L D Thierheimer; Özgün Babur; Anne D Rocheleau; Tao Huang; Jiaqing Pang; Rachel A Rigg; Annachiara Mitrugno; Dan Theodorescu; Julja Burchard; Xiaolin Nan; Emek Demir; Owen J T McCarty; Joseph E Aslan
Journal:  Am J Physiol Cell Physiol       Date:  2017-02-01       Impact factor: 4.249

3.  Platelet glycoprotein Ib-IX as a regulator of systemic inflammation.

Authors:  Adam Corken; Susan Russell; Judith Dent; Steven R Post; Jerry Ware
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-06       Impact factor: 8.311

Review 4.  Translational Implications of Platelets as Vascular First Responders.

Authors:  Richard C Becker; Travis Sexton; Susan S Smyth
Journal:  Circ Res       Date:  2018-02-02       Impact factor: 17.367

5.  Platelets Enhance Dendritic Cell Responses against Staphylococcus aureus through CD40-CD40L.

Authors:  Sharmeen Nishat; Leah M Wuescher; Randall G Worth
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

6.  Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial.

Authors:  Jessica C Cardenas; Xu Zhang; Erin E Fox; Bryan A Cotton; John R Hess; Martin A Schreiber; Charles E Wade; John B Holcomb
Journal:  Blood Adv       Date:  2018-07-24

Review 7.  Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management.

Authors:  Julie A Peterson; Janice G McFarland; Brian R Curtis; Richard H Aster
Journal:  Br J Haematol       Date:  2013-02-06       Impact factor: 6.998

Review 8.  The non-haemostatic role of platelets in systemic lupus erythematosus.

Authors:  Petrus Linge; Paul R Fortin; Christian Lood; Anders A Bengtsson; Eric Boilard
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

9.  Megakaryocytes and platelets from a novel human adipose tissue-derived mesenchymal stem cell line.

Authors:  Keiichi Tozawa; Yukako Ono-Uruga; Masaki Yazawa; Taisuke Mori; Mitsuru Murata; Shinichiro Okamoto; Yasuo Ikeda; Yumiko Matsubara
Journal:  Blood       Date:  2018-11-28       Impact factor: 22.113

10.  Fucoidan is a novel platelet agonist for the C-type lectin-like receptor 2 (CLEC-2).

Authors:  Bhanu Kanth Manne; Todd M Getz; Craig E Hughes; Osama Alshehri; Carol Dangelmaier; Ulhas P Naik; Steve P Watson; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.